Position in BIIB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$69,617,917
-$31,814,271 QoQ
Shares Held
379,741
-34.1% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
2.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 77.2110464764142.ToString("F0")%
Shared 0.ToString("F0")%
None 22.78895352358581.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Patient Capital Management, LLC holds $69,617,917 across 1 Drug Manufacturers - General name. BIIB ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
This page
|
379,741 | $69,617,917 |
All Filings in BIIB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $69,617,917 | 379,741 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $101,432,188 | 576,352 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $55,562,591 | 396,649 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $40,247,324 | 320,466 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $62,344,988 | 455,605 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $63,302,763 | 413,960 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $49,611,797 | 255,942 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $59,640,099 | 257,269 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $46,982,973 | 217,887 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||